Showing results (831-840 of 967) with videos related to
Sort By:
Pageof 97
Infectious Diseases and Therapy|November 3, 2020
Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter StudyToshifumi Tada, Takashi Kumada, Hiroaki Okushin, et al.Journal of Atherosclerosis and Thrombosis|September 13, 2023
Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized StudyKazuhiro Nakao, Teruo Noguchi, Hiroyuki Miura, et al.Annals of Gastroenterological Surgery|July 3, 2026
Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion SurgeryHisashi Kosaka, Masahiko Kinoshita, Satoshi Yasuda, et al.Atherosclerosis Plus|April 15, 2024
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.Hepatology Communications|November 9, 2020
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data ValidationDaniel Q Huang, Yee Hui Yeo, Eunice Tan, et al.Circulation|March 26, 2017
Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter RegistryKenichiro Yamagata, Minoru Horie, Takeshi Aiba, et al.Journal of Clinical Lipidology|January 21, 2026
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and non-obese patients with diabetes and coronary artery disease: OPTIMAL sub-analysisAnthony Salib, Yu Kataoka, Stephen J Nicholls, et al.European Journal of Gastroenterology & Hepatology|April 14, 2020
Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysisToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.Oncology|April 27, 2021
Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting AnalysisToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.Journal of Diabetes and Its Complications|September 23, 2023
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.Pageof 97